Lower and Higher Load Resistance Exercise Protocols: Acute Muscle Activation and Skeletal Muscle Hypertrophy
NCT ID: NCT03991117
Last Updated: 2019-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2016-01-04
2016-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Upper Versus Lower Limb Responses to Higher Versus Lower Load Resistance Training in Young Men
NCT03993483
Sex Differences in Muscle Damage Following Resistance Exercise at Low or High Intensity
NCT05111054
Muscle Response to High Intensity Interval Resistance Training (HIIRT)
NCT04321772
Resistance Training and Blood Flow Restriction
NCT04938947
Quantification of Internal Training Load
NCT06164249
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The total time commitment of this study will be \~7 hours. Each participant's first visit (familiarization) will include an interview through where the researchers will determine if there are any reasons that the participant cannot take part in the study. The researchers will explain the study protocol and, upon the participant's consent, the investigators will obtain the participant's knee extension maximum voluntary contraction (MVC) on a dynamometer (Biodex, Shirley, USA) and a 1 repetition-maximum (RM) test on a knee extension machine. Following that, the investigators will determine the next two dates (trial days) in which the participant will come in.
The participant will be asked to come in fasted on two separate trial days, each separated by two weeks, after the participant's familiarization visit. The participant will be required to avoid physical activity 48 hours before each of the three visits. There are four conditions in this study, each varying in relative load and speed of contraction. The participant will complete two conditions on each trial day, one with each leg. The conditions include: 80%RM Normal (80N; 1 eccentric: 1 pause: 1 concentric), 80% Slow (80S; 3:1:3), 30% Normal (30N; 1:1:1) and 30% Slow (30S; 3:1:3). Each condition will include three sets to voluntary failure on a knee extension machine. Before and after each set the participant will perform three MVCs on the dynamometer identical to what the participant did on the familiarization day. The investigators will record the participant's rating of perceived exertion and effort via the Borg scale and electromyography (EMG), respectively. The participant will have one biopsy taken pre-training and two, one per condition/leg, one hour post-training.
The REB Project Number for this study is: 802
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
30 %1RM, Slow Tempo
Participants performed three sets of unilateral knee extension with a load that was 30 % of their one-repetition maximum (1RM) at a tempo of seven seconds per repetition.
resistance exercise
unilateral knee extensions until fatigue with varying load and speeds of contraction
80 %1RM, Regular Tempo
Participants performed three sets of unilateral knee extension with a load that was 80 % of their one-repetition maximum (1RM) at a tempo of three seconds per repetition.
resistance exercise
unilateral knee extensions until fatigue with varying load and speeds of contraction
80 %1RM, Slow Tempo
Participants performed three sets of unilateral knee extension with a load that was 80 % of their one-repetition maximum (1RM) at a tempo of seven seconds per repetition.
resistance exercise
unilateral knee extensions until fatigue with varying load and speeds of contraction
30 %1RM, Regular Tempo
Participants performed three sets of unilateral knee extension with a load that was 30 % of their one-repetition maximum (1RM) at a tempo of three seconds per repetition.
resistance exercise
unilateral knee extensions until fatigue with varying load and speeds of contraction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
resistance exercise
unilateral knee extensions until fatigue with varying load and speeds of contraction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* male
* 18-30 years of age
Exclusion Criteria
* Experience arthritic conditions
* Smoke tobacco products
* Consume any analgesic or anti-inflammatory drug(s), prescription or non-prescription, chronically
* Have a history of neuromuscular complications
* Are on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications).
* Have an extensive history of RE training in the year prior to study entry.
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McMaster University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stuart Phillips
Tier 1 Canada Research Chair and Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stuart Phillips, PhD
Role: PRINCIPAL_INVESTIGATOR
McMaster University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HIREB 0802
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.